Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage IV or Recurrent Melanoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating a vaccine therapy for stage IV or recurrent melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Lisata Therapeutics, Inc. | Conditions: Melanoma (Skin) | Phase 1, Phase 2 | Status: COMPLETED